US2005112556A1PendingUtilityA1

Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens

Priority: Jul 22, 1997Filed: Sep 14, 2004Published: May 26, 2005
Est. expiryJul 22, 2017(expired)· nominal 20-yr term from priority
C12N 2740/13021G01N 33/502G01N 33/5047A01K 2217/05G01N 33/56983G01N 33/5008C07K 14/005G01N 2800/24C12Q 1/48C12N 2740/13022C12Q 1/702G01N 33/564G01N 33/5091G01N 33/505G01N 33/68G01N 2333/15C12Q 2600/158A61P 37/00A61P 3/10C12Q 1/686A61K 38/00G01N 33/56977A01K 2267/0325G01N 33/5052A01K 2217/20A01K 67/0275C12N 2740/10022G01N 2800/042G01N 2500/00A01K 2227/105
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to a process for the diagnosis of a human autoimmune disease, including presymptomatic diagnosis, said human autoimmune disease being associated with human retrovirus (HERV) having Superantigen (SAg) activity, comprising specifically detecting in a biological sample of human origin at least one of the following: (I) the mRNA of an expressed human endogenous retrovirus having Superantigen (SAg) activity, or fragments of such expressed retroviral mRNA, said retrovirus being associated with a given autoimmune disease, or (II) protein or peptide expressed by said retrovirus, or (III) antibodies specific to the protein expressed by said endogenous, or (IV) SAg activity specifically associated with said endogenous retrovirus, detection of any of the species (I) to (IV) indicating presence of autoimmune disease or imminent onset of autoimmune disease.

Claims

exact text as granted — not AI-modified
1 . Process for the diagnosis of a human autoimmune disease, including pre-symptomatic diagnosis, said human autoimmune disease being associated with human endogenous retrovirus (HERV) having Superantigen (SAg) activity, comprising specifically detecting in a biological sample of human origin at least one of the following: 
 I—the mRNA of an expressed human endogenous retrovirus having Superantigen (SAg) activity, or fragments of such expressed retroviral mRNA, said retrovirus being associated with a given autoimmune disease, or    II—protein or peptide expressed by said retrovirus, or    III—antibodies specific to the proteins expressed by said endogenous retrovirus, or    IV—SAg activity specifically associated with said endogenous retrovirus, detection of any of the species (I) to (IV) indicating presence of autoimmune disease or imminent onset of autoimmune disease.    
     
     
         2 .- 61 . (canceled)

Join the waitlist — get patent alerts

Track US2005112556A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.